A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Clinical trial NCT04913285 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04913285
Sponsor: Pierre Fabre Medicament
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Non-small Cell Lung Cancer Melanoma

Start date: 2021-08-04
Primary completion: 2028-11-30
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.